The story has also been updated to include mention of mRNA vaccine experiments in early patent filings.References Malone, R. W., Felgner, P. L. & Verma, I. M. Proc. Natl Acad. Sci. USA 86, 6077–6081 (1989). Article PubMed Google Scholar Malone, R. W. Focus 11, 61–66 (...
2020, Donald Trump promised to, “produce a vaccine before the end of the year, or maybe even sooner” (Reich and Masket2020). Trump added, “Nobody thought it could be done this fast. Normally it would be years, and we did it in a matter of a few months. We...
Our international team of renowned researchers has tapped into the potential of mRNA. Read all about 30 years of research and the milestones achieved here.
Claim :Japan called mRNA COVID vaccine deadliest drug in history! People are sharing an article (archive) byThe People’s Voice(formerlyNewsPunch), which claimed that Japan officially named the mRNA COVID-190 vaccine as the deadliest drug in history! Here is an excerpt of the (intentionally?
resumed after researchers and regulators determined that there was no clear connection between the vaccine and the medical events and deemed them safe enough to continue. No adverse events have yet been linked to the mRNA vaccine candidates, except for a handful of allergic reactio...
designed the first mRNA vaccine for the treatment of cancer in 1995. They reported that their vector, which expressed human carcinoembryonic antigen (CEA), could safely be injected into CEA-expressing tumor cells in a mouse model26. However, it took a long time for these animal experiments to...
Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obst
such as vaccine-specific clones or leukemia/lymphoma clones, and for studying the functional/phenotypic evolution of specific TCR/BCR clonotypes. On the other hand, as the expression of TCR/BCR varied significantly among different types/status of T/B cells, such as on naïve cells and plasmabl...
The goal of mRNA vaccine technology is to make proteins unique to the virus without injecting the body with the virus itself. To do this, scientists design mRNA that will provide instructions for the protein-making-machinery in our bodies to make a protein unique to the specific virus. The ...
Thereafter, the first industrial development of this technology began in Germany in 2000, with the founding of CureVac, which stemmed from another description of a synthetic mRNA vaccine published in EJI in 2000. The first clinical studies investigating mRNA vaccines in humans were...